MYC and acute myeloid leukemia: MYC is significantly inhibited in I-BET151-susceptible cells, but it is not affected in I-BET151-resistant cells, indicating a functional compensation for MYC in I-BET151-resistant AML cells, which is related to enhancer remodeling.